25 XP   0   0   10

Dare Bioscience Inc
Buy, Hold or Sell?

Let's analyse Dare Bioscience Inc together

PenkeI guess you are interested in Dare Bioscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dare Bioscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dare Bioscience Inc

I send you an email if I find something interesting about Dare Bioscience Inc.

Quick analysis of Dare Bioscience Inc (30 sec.)










What can you expect buying and holding a share of Dare Bioscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$-0.31
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.29
Return On Investment
-59.3%

For what price can you sell your share?

Current Price per Share
$0.49
Expected price per share
$0.45 - $0.66
How sure are you?
50%

1. Valuation of Dare Bioscience Inc (5 min.)




Live pricePrice per Share (EOD)

$0.49

Intrinsic Value Per Share

$-3.83 - $-4.46

Total Value Per Share

$-3.85 - $-4.48

2. Growth of Dare Bioscience Inc (5 min.)




Is Dare Bioscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.2m$32.2m-$29.4m-1,064.8%

How much money is Dare Bioscience Inc making?

Current yearPrevious yearGrowGrow %
Making money$99.2m-$6.1m$105.3m106.2%
Net Profit Margin-206.4%1.0%--

How much money comes from the company's main activities?

3. Financial Health of Dare Bioscience Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#921 / 1031

Most Revenue
#7 / 1031

Most Profit
#25 / 1031

Most Efficient
#664 / 1031

What can you expect buying and holding a share of Dare Bioscience Inc? (5 min.)

Welcome investor! Dare Bioscience Inc's management wants to use your money to grow the business. In return you get a share of Dare Bioscience Inc.

What can you expect buying and holding a share of Dare Bioscience Inc?

First you should know what it really means to hold a share of Dare Bioscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Dare Bioscience Inc is $0.4902. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dare Bioscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dare Bioscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dare Bioscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-17.2%-0.10-21.2%-0.06-12.7%-0.07-14.5%-0.07-14.0%
Usd Book Value Change Per Share0.000.9%-0.07-14.8%-0.01-2.9%-0.01-1.2%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.4082.4%0.2041.2%
Usd Total Gains Per Share0.000.9%-0.07-14.8%-0.01-2.9%0.4081.2%0.2041.1%
Usd Price Per Share0.46-0.81-1.43-1.15-1.88-
Price to Earnings Ratio-1.37--2.10-15.04--0.52--3.05-
Price-to-Total Gains Ratio105.69-17.99-12.90-3.57--12.55-
Price to Book Ratio-19.89--6.22-4.31-24.97-16.84-
Price-to-Total Gains Ratio105.69-17.99-12.90-3.57--12.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4902
Number of shares2039
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.40
Usd Book Value Change Per Share-0.07-0.01
Usd Total Gains Per Share-0.070.40
Gains per Quarter (2039 shares)-148.08811.57
Gains per Year (2039 shares)-592.333,246.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-592-6023295-493236
20-1185-11946591-986482
30-1777-17869886-1479728
40-2369-237813182-19612974
50-2962-297016477-24616220
60-3554-356219772-29519466
70-4146-415423068-34422712
80-4739-474626363-39325958
90-5331-533829658-44229204
100-5923-593032954-49132450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%2.038.00.05.0%2.038.00.05.0%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%8.011.01.040.0%12.027.01.030.0%12.027.01.030.0%
Dividend per Share0.00.04.00.0%2.00.010.016.7%4.00.016.020.0%4.00.036.010.0%4.00.036.010.0%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%9.010.01.045.0%13.026.01.032.5%13.026.01.032.5%

Fundamentals of Dare Bioscience Inc

About Dare Bioscience Inc

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder; and DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy. The company's Phase I-ready products are DARE-VVA1, a proprietary formulation of tamoxifen for intravaginal to treat vulvar vaginal atrophy in women with hormone-receptor positive breast cancer; DARE-PDM1, a proprietary hydrogel formulation of diclofenac, a nonsteroidal anti-inflammatory drug, for vaginal administration as a treatment for dysmenorrhea; DARE-204 and DARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-GML, an intravaginally-delivered potential multi-target antimicrobial agent formulated with glycerol monolaurate; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal healt

Fundamental data was last updated by Penke on 2024-03-20 15:04:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Dare Bioscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dare Bioscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -829.9% means that $-8.30 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dare Bioscience Inc:

  • The MRQ is -829.9%. The company is making a huge loss. -2
  • The TTM is -206.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-829.9%TTM-206.4%-623.5%
TTM-206.4%YOY1.0%-207.5%
TTM-206.4%5Y-41.1%-165.3%
5Y-41.1%10Y-2,462.9%+2,421.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-829.9%-159.2%-670.7%
TTM-206.4%-202.3%-4.1%
YOY1.0%-263.0%+264.0%
5Y-41.1%-452.4%+411.3%
10Y-2,462.9%-589.0%-1,873.9%
1.1.2. Return on Assets

Shows how efficient Dare Bioscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • -33.1% Return on Assets means that Dare Bioscience Inc generated $-0.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dare Bioscience Inc:

  • The MRQ is -33.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 216.5%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-33.1%TTM216.5%-249.6%
TTM216.5%YOY-11.8%+228.2%
TTM216.5%5Y2.9%+213.6%
5Y2.9%10Y-11.1%+14.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.1%-12.5%-20.6%
TTM216.5%-12.2%+228.7%
YOY-11.8%-11.2%-0.6%
5Y2.9%-13.3%+16.2%
10Y-11.1%-14.6%+3.5%
1.1.3. Return on Equity

Shows how efficient Dare Bioscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Dare Bioscience Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dare Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM910.0%-910.0%
TTM910.0%YOY-19.2%+929.2%
TTM910.0%5Y-23.5%+933.5%
5Y-23.5%10Y-28.2%+4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.0%+16.0%
TTM910.0%-15.8%+925.8%
YOY-19.2%-13.9%-5.3%
5Y-23.5%-18.2%-5.3%
10Y-28.2%-19.1%-9.1%

1.2. Operating Efficiency of Dare Bioscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dare Bioscience Inc is operating .

  • Measures how much profit Dare Bioscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • An Operating Margin of -840.6% means the company generated $-8.41  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dare Bioscience Inc:

  • The MRQ is -840.6%. The company is operating very inefficient. -2
  • The TTM is -210.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-840.6%TTM-210.2%-630.4%
TTM-210.2%YOY1.0%-211.1%
TTM-210.2%5Y-41.8%-168.3%
5Y-41.8%10Y-2,053.9%+2,012.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-840.6%-299.5%-541.1%
TTM-210.2%-208.5%-1.7%
YOY1.0%-280.2%+281.2%
5Y-41.8%-459.9%+418.1%
10Y-2,053.9%-596.9%-1,457.0%
1.2.2. Operating Ratio

Measures how efficient Dare Bioscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 9.41 means that the operating costs are $9.41 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Dare Bioscience Inc:

  • The MRQ is 9.406. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.352. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.406TTM2.352+7.054
TTM2.352YOY0.240+2.111
TTM2.3525Y0.518+1.833
5Y0.51810Y20.860-20.341
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.4062.817+6.589
TTM2.3523.181-0.829
YOY0.2403.609-3.369
5Y0.5185.554-5.036
10Y20.8607.396+13.464

1.3. Liquidity of Dare Bioscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dare Bioscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.85 means the company has $0.85 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Dare Bioscience Inc:

  • The MRQ is 0.852. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.081. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.852TTM1.081-0.230
TTM1.081YOY2.890-1.809
TTM1.0815Y2.367-1.285
5Y2.36710Y4.656-2.289
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8523.987-3.135
TTM1.0814.440-3.359
YOY2.8905.569-2.679
5Y2.3676.158-3.791
10Y4.6566.492-1.836
1.3.2. Quick Ratio

Measures if Dare Bioscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.57 means the company can pay off $0.57 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dare Bioscience Inc:

  • The MRQ is 0.570. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.799. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.570TTM0.799-0.229
TTM0.799YOY2.584-1.785
TTM0.7995Y2.053-1.254
5Y2.05310Y4.415-2.362
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5703.653-3.083
TTM0.7994.158-3.359
YOY2.5845.515-2.931
5Y2.0536.012-3.959
10Y4.4156.206-1.791

1.4. Solvency of Dare Bioscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dare Bioscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dare Bioscience Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.09 means that Dare Bioscience Inc assets are financed with 109.1% credit (debt) and the remaining percentage (100% - 109.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dare Bioscience Inc:

  • The MRQ is 1.091. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.948. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.091TTM0.948+0.144
TTM0.948YOY0.378+0.570
TTM0.9485Y0.643+0.305
5Y0.64310Y0.714-0.071
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0910.336+0.755
TTM0.9480.330+0.618
YOY0.3780.267+0.111
5Y0.6430.367+0.276
10Y0.7140.378+0.336
1.4.2. Debt to Equity Ratio

Measures if Dare Bioscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dare Bioscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.013-2.013
TTM2.013YOY0.625+1.388
TTM2.0135Y3.036-1.023
5Y3.03610Y1.759+1.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM2.0130.398+1.615
YOY0.6250.334+0.291
5Y3.0360.431+2.605
10Y1.7590.476+1.283

2. Market Valuation of Dare Bioscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dare Bioscience Inc generates.

  • Above 15 is considered overpriced but always compare Dare Bioscience Inc to the Biotechnology industry mean.
  • A PE ratio of -1.37 means the investor is paying $-1.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dare Bioscience Inc:

  • The EOD is -1.455. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.371. Based on the earnings, the company is expensive. -2
  • The TTM is -2.100. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.455MRQ-1.371-0.084
MRQ-1.371TTM-2.100+0.729
TTM-2.100YOY15.040-17.140
TTM-2.1005Y-0.518-1.582
5Y-0.51810Y-3.045+2.527
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.455-2.697+1.242
MRQ-1.371-2.422+1.051
TTM-2.100-2.709+0.609
YOY15.040-4.116+19.156
5Y-0.518-6.257+5.739
10Y-3.045-6.478+3.433
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dare Bioscience Inc:

  • The EOD is -1.511. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.423. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.471. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.511MRQ-1.423-0.088
MRQ-1.423TTM-2.471+1.048
TTM-2.471YOY-1.423-1.048
TTM-2.4715Y-1.871-0.600
5Y-1.87110Y-7.086+5.215
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.511-3.344+1.833
MRQ-1.423-2.939+1.516
TTM-2.471-3.486+1.015
YOY-1.423-5.592+4.169
5Y-1.871-8.464+6.593
10Y-7.086-8.872+1.786
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dare Bioscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -19.89 means the investor is paying $-19.89 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Dare Bioscience Inc:

  • The EOD is -21.110. Based on the equity, the company is expensive. -2
  • The MRQ is -19.887. Based on the equity, the company is expensive. -2
  • The TTM is -6.223. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.110MRQ-19.887-1.223
MRQ-19.887TTM-6.223-13.664
TTM-6.223YOY4.313-10.537
TTM-6.2235Y24.967-31.190
5Y24.96710Y16.843+8.124
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-21.1102.198-23.308
MRQ-19.8872.042-21.929
TTM-6.2232.121-8.344
YOY4.3132.907+1.406
5Y24.9673.682+21.285
10Y16.8434.114+12.729
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Dare Bioscience Inc.

3.1. Institutions holding Dare Bioscience Inc

Institutions are holding 6.78% of the shares of Dare Bioscience Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.49890344861239370.1143
2023-12-31Geode Capital Management, LLC0.9853097111915314018.7218
2023-12-31Renaissance Technologies Corp0.72990.0003719400486007.2451
2023-12-31BlackRock Inc0.40850402645-2360-0.5827
2023-12-31State Street Corporation0.2513024771000
2023-12-31Northern Trust Corp0.18601833022198613.6292
2023-09-30Citadel Advisors Llc0.1343013238682485165.2973
2023-12-31T. Rowe Price Associates, Inc.0.1277012590000
2023-12-31Founders Financial Securities, LLC0.12580.004312400000
2023-09-30InterWest Venture Management Co0.0630.13896206500
2023-12-31HighTower Advisors, LLC0.047404670036000336.4486
2023-12-31VISIONARY HORIZONS LLC0.03780.009337250372500
2023-12-31Commonwealth Equity Services Inc0.0331032625-16704-33.8624
2023-12-31Wealth Enhancement Advisory Services, LLC0.0313030875308750
2023-12-31Charles Schwab Investment Management Inc0.03103053200
2023-12-31Raymond James Finl Svs Advisors, Inc.0.028027589758937.945
2023-12-31Bank of New York Mellon Corp0.0273026947400017.4315
2023-12-31Tower Research Capital LLC0.02590.000125524509524.94
2023-09-30JANE STREET GROUP, LLC0.0254025009250090
2023-12-31Zuckerman Investment Group, LLC0.02340.00092306000
Total 6.82130.15386723250+436902+6.5%

3.2. Funds holding Dare Bioscience Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.40980.0001237513300
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.95990.000594608600
2024-01-31Fidelity Extended Market Index0.60730.000559857300
2024-02-29iShares Micro-Cap ETF0.20250.0126199622178769.8357
2023-09-30BlackRock Extended Mkt Composite0.19460.000619176000
2024-01-31Fidelity Total Market Index0.18960.000118689500
2023-12-31BlackRock Extended Equity Market K0.16970.0004167295-337-0.201
2023-12-31T. Rowe Price U.S. Equities Tr0.12770.000412590000
2024-01-31Fidelity Series Total Market Index0.09840.00019701100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0960.0005946582624138.3545
2023-12-31Northern Trust Extended Eq Market Idx0.0960.0005946582624138.3545
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08550.00048430300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06870.0004677071270.1879
2024-02-29Vanguard Balanced Index Inv0.0480.00014727000
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.04550.00014484300
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.04550.000144843-2330290-98.112
2024-01-31Spartan Total Market Index Pool E0.036403592200
2024-02-29Vanguard U.S. Eq Idx £ Acc0.03580.00013528000
2024-01-31Schwab Total Stock Market Index0.0310.00013053200
2024-01-31Fidelity Nasdaq Composite Index0.03040.00012999400
Total 5.57830.01775498285-2260142-41.1%

3.3. Insider Transactions

Insiders are holding 1.687% of the shares of Dare Bioscience Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2019-04-11Roger HawleyBUY4545451.1
2018-06-11Roger HawleyBUY1400001.45
2016-02-22David R WaltBUY22912.08166900
2016-02-18David R. WaltBUY89602.1165200
2016-02-16David R. WaltBUY88112156240
2016-02-11David R. WaltBUY88502.05147429
2016-02-09David R. WaltBUY90002.15138579
2016-02-05David R. WaltBUY85632.3129579
2016-02-03David R. WaltBUY84132.32121016
2016-02-01David R. WaltBUY57002.38112603
2016-01-28David R. WaltBUY90002.46106903
2016-01-26David R. WaltBUY88002.3997903
2016-01-25David R. WaltBUY45002.3597903
2016-01-22David R. WaltBUY90002.2889103
2016-01-20David R. WaltBUY89002.4380103
2016-01-15David R. WaltBUY85722.5371203
2016-01-13David R. WaltBUY86842.7962631
2016-01-11David R. WaltBUY88552.8753947
2016-01-07David R. WaltBUY88002.9545092
2016-01-05David R. WaltBUY88013.0336292

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Dare Bioscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.004-0.073+1762%-0.014+422%-0.006+238%-0.001+113%
Book Value Per Share---0.0230.028-183%0.327-107%0.104-122%0.166-114%
Current Ratio--0.8521.081-21%2.890-71%2.367-64%4.656-82%
Debt To Asset Ratio--1.0910.948+15%0.378+189%0.643+70%0.714+53%
Debt To Equity Ratio---2.013-100%0.625-100%3.036-100%1.759-100%
Dividend Per Share----0%-0%0.404-100%0.202-100%
Eps---0.084-0.104+24%-0.062-26%-0.071-16%-0.069-18%
Free Cash Flow Per Share---0.081-0.093+14%-0.093+15%-0.073-10%-0.062-24%
Free Cash Flow To Equity Per Share--0.006-0.067+1232%-0.046+876%2.598-100%1.345-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%42.429-98%
Intrinsic Value_10Y_max---4.459--------
Intrinsic Value_10Y_min---3.826--------
Intrinsic Value_1Y_max---0.358--------
Intrinsic Value_1Y_min---0.352--------
Intrinsic Value_3Y_max---1.144--------
Intrinsic Value_3Y_min---1.091--------
Intrinsic Value_5Y_max---2.011--------
Intrinsic Value_5Y_min---1.861--------
Market Cap48315241.421+6%45516071.98779882283.334-43%140944094.720-68%113098765.405-60%185711586.008-75%
Net Profit Margin---8.299-2.064-75%0.010-80285%-0.411-95%-24.629+197%
Operating Margin---8.406-2.102-75%0.010-87586%-0.418-95%-20.539+144%
Operating Ratio--9.4062.352+300%0.240+3813%0.518+1714%20.860-55%
Pb Ratio-21.110-6%-19.887-6.223-69%4.313-561%24.967-180%16.843-218%
Pe Ratio-1.455-6%-1.371-2.100+53%15.040-109%-0.518-62%-3.045+122%
Price Per Share0.490+6%0.4620.810-43%1.430-68%1.147-60%1.884-75%
Price To Free Cash Flow Ratio-1.511-6%-1.423-2.471+74%-1.423+0%-1.871+31%-7.086+398%
Price To Total Gains Ratio112.188+6%105.68917.990+487%12.900+719%3.566+2863%-12.546+112%
Quick Ratio--0.5700.799-29%2.584-78%2.053-72%4.415-87%
Return On Assets---0.3312.165-115%-0.118-64%0.029-1249%-0.111-66%
Return On Equity---9.100-100%-0.1920%-0.2350%-0.2820%
Total Gains Per Share--0.004-0.073+1762%-0.014+422%0.398-99%0.201-98%
Usd Book Value---2288740.0002768892.000-183%32252615.500-107%10237589.400-122%16332039.375-114%
Usd Book Value Change Per Share--0.004-0.073+1762%-0.014+422%-0.006+238%-0.001+113%
Usd Book Value Per Share---0.0230.028-183%0.327-107%0.104-122%0.166-114%
Usd Dividend Per Share----0%-0%0.404-100%0.202-100%
Usd Eps---0.084-0.104+24%-0.062-26%-0.071-16%-0.069-18%
Usd Free Cash Flow---7995930.000-9149804.250+14%-9173007.000+15%-7232566.300-10%-6089328.425-24%
Usd Free Cash Flow Per Share---0.081-0.093+14%-0.093+15%-0.073-10%-0.062-24%
Usd Free Cash Flow To Equity Per Share--0.006-0.067+1232%-0.046+876%2.598-100%1.345-100%
Usd Market Cap48315241.421+6%45516071.98779882283.334-43%140944094.720-68%113098765.405-60%185711586.008-75%
Usd Price Per Share0.490+6%0.4620.810-43%1.430-68%1.147-60%1.884-75%
Usd Profit---8299096.00099231036.500-108%-6106516.750-26%14944920.800-156%3953002.350-310%
Usd Revenue--1000000.0002500250000.000-100%2500000.000-60%500550000.000-100%250401100.000-100%
Usd Total Gains Per Share--0.004-0.073+1762%-0.014+422%0.398-99%0.201-98%
 EOD+7 -1MRQTTM+15 -18YOY+14 -185Y+7 -2710Y+9 -26

4.2. Fundamental Score

Let's check the fundamental score of Dare Bioscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.455
Price to Book Ratio (EOD)Between0-1-21.110
Net Profit Margin (MRQ)Greater than0-8.299
Operating Margin (MRQ)Greater than0-8.406
Quick Ratio (MRQ)Greater than10.570
Current Ratio (MRQ)Greater than10.852
Debt to Asset Ratio (MRQ)Less than11.091
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.331
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Dare Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.084
Ma 20Greater thanMa 500.500
Ma 50Greater thanMa 1000.422
Ma 100Greater thanMa 2000.381
OpenGreater thanClose0.550
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets25,054
Total Liabilities27,343
Total Stockholder Equity-2,289
 As reported
Total Liabilities 27,343
Total Stockholder Equity+ -2,289
Total Assets = 25,054

Assets

Total Assets25,054
Total Current Assets22,435
Long-term Assets2,619
Total Current Assets
Cash And Cash Equivalents 13,894
Net Receivables 1,130
Inventory 6,580
Other Current Assets 831
Total Current Assets  (as reported)22,435
Total Current Assets  (calculated)22,435
+/-0
Long-term Assets
Property Plant Equipment 59
Long-term Assets Other 2,225
Long-term Assets  (as reported)2,619
Long-term Assets  (calculated)2,284
+/- 335

Liabilities & Shareholders' Equity

Total Current Liabilities26,343
Long-term Liabilities1,000
Total Stockholder Equity-2,289
Total Current Liabilities
Short-term Debt 195
Accounts payable 4,987
Other Current Liabilities 5,293
Total Current Liabilities  (as reported)26,343
Total Current Liabilities  (calculated)10,475
+/- 15,868
Long-term Liabilities
Capital Lease Obligations 195
Long-term Liabilities  (as reported)1,000
Long-term Liabilities  (calculated)195
+/- 805
Total Stockholder Equity
Common Stock10
Retained Earnings -166,178
Accumulated Other Comprehensive Income -419
Other Stockholders Equity 164,299
Total Stockholder Equity (as reported)-2,289
Total Stockholder Equity (calculated)-2,289
+/-0
Other
Capital Stock10
Cash and Short Term Investments 13,894
Common Stock Shares Outstanding 91,052
Current Deferred Revenue15,868
Liabilities and Stockholders Equity 25,054
Net Debt -13,700
Net Invested Capital -2,289
Net Working Capital -3,907
Short Long Term Debt Total 195



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
0
0
0
6,827
11,854
65,739
60,086
53,393
59,381
88,104
80,117
78,225
63,024
49,892
40,133
37,688
15,953
8,151
23,267
14,260
16,631
13,484
10,796
7,827
7,827
7,261
3,882
7,443
10,214
8,570
7,662
7,551
10,518
14,822
48,811
55,807
49,187
51,394
50,376
43,826
30,367
23,210
25,054
25,05423,21030,36743,82650,37651,39449,18755,80748,81114,82210,5187,5517,6628,57010,2147,4433,8827,2617,8277,82710,79613,48416,63114,26023,2678,15115,95337,68840,13349,89263,02478,22580,11788,10459,38153,39360,08665,73911,8546,827000
   > Total Current Assets 
0
0
0
6,447
11,501
65,394
59,698
52,836
58,582
87,085
79,153
77,302
62,101
48,922
39,204
36,790
15,609
8,134
10,383
8,349
15,945
12,819
10,168
7,240
7,240
6,562
3,243
6,444
9,322
7,777
6,984
6,984
9,599
14,059
48,243
55,296
47,817
50,113
49,567
43,039
29,512
22,243
22,435
22,43522,24329,51243,03949,56750,11347,81755,29648,24314,0599,5996,9846,9847,7779,3226,4443,2436,5627,2407,24010,16812,81915,9458,34910,3838,13415,60936,79039,20448,92262,10177,30279,15387,08558,58252,83659,69865,39411,5016,447000
       Cash And Cash Equivalents 
0
0
0
5,488
8,468
64,271
57,786
51,174
56,316
85,476
77,631
75,908
60,515
47,193
38,058
34,950
12,028
7,244
8,529
7,560
15,625
12,447
9,537
6,806
6,806
5,631
2,435
4,780
5,047
5,347
5,389
4,669
7,660
9,112
45,571
51,674
39,317
32,071
40,390
34,670
19,829
13,329
13,894
13,89413,32919,82934,67040,39032,07139,31751,67445,5719,1127,6604,6695,3895,3475,0474,7802,4355,6316,8066,8069,53712,44715,6257,5608,5297,24412,02834,95038,05847,19360,51575,90877,63185,47656,31651,17457,78664,2718,4685,488000
       Net Receivables 
0
0
0
959
3,033
1,123
1,912
1,662
2,266
1,609
1,522
1,394
1,586
1,729
1,146
1,840
1,139
890
711
284
29
25
80
31
31
493
38
555
430
177
214
460
302
2,955
156
1,145
1,730
12,138
2,292
1,703
2,399
572
1,130
1,1305722,3991,7032,29212,1381,7301,1451562,9553024602141774305553849331318025292847118901,1391,8401,1461,7291,5861,3941,5221,6092,2661,6621,9121,1233,033959000
       Other Current Assets 
0
0
0
0
3,033,000
1,123,000
1,912,000
1,662
2,266
1,609
1,522
1,394
1,586
1,729
1,146
1,840
386
890
1,143
193
291
347
550
403
403
438
771
1,109
3,845
2,253
1,381
1,854
1,637
1,992
2,516
2,477
6,770
5,904
6,885
6,666
201
272
831
8312722016,6666,8855,9046,7702,4772,5161,9921,6371,8541,3812,2533,8451,1097714384034035503472911931,1438903861,8401,1461,7291,5861,3941,5221,6092,2661,6621,912,0001,123,0003,033,0000000
   > Long-term Assets 
0
0
0
380
353
345
388
557
799
1,019
964
923
923
970
929
898
344
17
12,883
5,911
686
665
628
587
587
699
639
999
892
794
677
567
919
763
568
511
1,369
1,282
809
788
855
967
2,619
2,6199678557888091,2821,3695115687639195676777948929996396995875876286656865,91112,883173448989299709239239641,019799557388345353380000
       Property Plant Equipment 
0
0
0
245
223
221
268
342
330
366
354
576
693
740
699
668
114
17
0
0
0
8
11
9
9
7
6
552
52
425
348
277
32
25
33
243
25
21
73
523
55
46
59
59465552373212524333253227734842552552679911800017114668699740693576354366330342268221223245000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,881
5,188
5,188
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000005,1885,18812,881000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,881
5,188
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000005,18812,881000000000000000000
       Other Assets 
0
0
0
0
130
124
120
215
469
653
610
347
230
230
230
0
230
0
12,884
5,911
686
657
617
578
538
499
459
447
409
369
635
529
418
350
535
268
144
1,261
737
0
0
645
0
0645007371,2611442685353504185296353694094474594995385786176576865,91112,884023002302302303476106534692151201241300000
> Total Liabilities 
0
0
0
9,615
108,892
7,931
7,554
8,068
18,973
19,902
21,474
29,482
27,041
24,052
23,514
24,577
8,212
4,092
840
967
810
1,266
1,212
1,101
1,101
2,178
2,072
7,002
7,000
8,259
9,048
8,702
7,260
7,078
16,923
17,053
18,308
18,361
24,033
32,714
25,395
25,929
27,343
27,34325,92925,39532,71424,03318,36118,30817,05316,9237,0787,2608,7029,0488,2597,0007,0022,0722,1781,1011,1011,2121,2668109678404,0928,21224,57723,51424,05227,04129,48221,47419,90218,9738,0687,5547,931108,8929,615000
   > Total Current Liabilities 
0
0
0
6,088
24,180
5,963
6,379
8,061
5,289
7,845
10,608
16,337
15,581
14,462
15,889
16,939
6,682
3,349
839
967
808
1,265
1,203
1,091
1,091
1,974
1,889
5,612
4,716
6,084
7,965
7,661
6,108
6,005
15,907
16,053
16,395
16,537
22,838
31,624
24,338
24,701
26,343
26,34324,70124,33831,62422,83816,53716,39516,05315,9076,0056,1087,6617,9656,0844,7165,6121,8891,9741,0911,0911,2031,2658089678393,3496,68216,93915,88914,46215,58116,33710,6087,8455,2898,0616,3795,96324,1806,088000
       Short-term Debt 
0
0
0
3,134
20,527
3,274
3,347
3,124
836
2,654
4,031
7,652
7,832
8,017
8,192
8,382
8,382
853
0
0
0
0
0
0
0
0
0
411
404
784
777
715
444
419
368
271
294
324
388
398
336
272
195
1952723363983883242942713684194447157777844044110000000008538,3828,3828,1928,0177,8327,6524,0312,6548363,1243,3473,27420,5273,134000
       Short Long Term Debt 
0
0
0
0
0
0
0
3,124
0
0
0
500
0
0
8,192
698
0
853
0
0
0
0
0
0
0
0
0
0
0
367
367
367
0
0
0
0
0
0
0
0
0
0
0
000000000003673673670000000000085306988,192005000003,1240000000
       Accounts payable 
0
0
0
914
2,160
579
1,461
1,255
1,682
1,808
2,158
2,226
2,190
1,593
1,778
1,446
644
660
839
308
808
1,265
1,203
1,091
460
632
352
1,083
1,531
1,714
1,555
1,021
1,472
216
606
2,103
2,831
1,114
3,477
2,028
2,696
6,541
4,987
4,9876,5412,6962,0283,4771,1142,8312,1036062161,4721,0211,5551,7141,5311,0833526324601,0911,2031,2658083088396606441,4461,7781,5932,1902,2262,1581,8081,6821,2551,4615792,160914000
       Other Current Liabilities 
0
0
0
2,040
1,493
2,110
1,571
34
35
27
17
6,459
5,559
4,852
5,919
4,611
3,538
189
0
658
808
0
0
0
631
1,342
1,537
2,099
1,691
1,641
3,454
4,360
3,520
4,370
3,777
3,136
3,538
6,347
4,136
10,894
5,480
4,194
5,293
5,2934,1945,48010,8944,1366,3473,5383,1363,7774,3703,5204,3603,4541,6411,6912,0991,5371,34263100080865801893,5384,6115,9194,8525,5596,459172735341,5712,1101,4932,040000
   > Long-term Liabilities 
0
0
0
3,527
84,712
1,968
1,175
7
13,684
12,057
10,866
13,145
11,460
9,590
7,625
7,638
1,530
743
0
0
3
0
9
10
10
204
183
1,390
2,284
2,175
1,083
1,042
1,152
1,074
1,016
1,000
1,913
1,824
1,195
1,090
1,057
1,229
1,000
1,0001,2291,0571,0901,1951,8241,9131,0001,0161,0741,1521,0421,0832,1752,2841,3901832041010903007431,5307,6387,6259,59011,46013,14510,86612,05713,68471,1751,96884,7123,527000
       Long term Debt Total 
0
0
0
0
2,297
1,451
587
0
13,576
11,833
10,530
12,672
10,687
8,649
6,550
4,439
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000004,4396,5508,64910,68712,67210,53011,83313,57605871,4512,2970000
       Warrants
0
0
0
0
81,525
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000081,5250000
       Other Liabilities 
0
0
0
0
0
0
0
7
0
0
0
473
0
0
1,075
1,206
162
0
1
0
3
0
9
10
84
88
92
1,000
2,000
2,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
0
0
1,205
0
01,205001,0001,0001,0001,0001,0001,0001,0001,0001,0002,0002,0001,000928884109030101621,2061,0750047300070000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,993
1,368
743
0
0
3
0
9
10
0
0
0
0
0
0
0
0
0
0
0
143
0
0
0
0
0
0
0
00000001430000000000010903007431,3681,993000000000000000
> Total Stockholder Equity
0
0
0
-2,788
-97,038
57,808
52,532
45,325
40,408
68,202
58,643
48,743
35,983
25,840
16,619
13,111
7,741
4,059
22,427
13,293
15,820
12,218
9,584
6,727
6,727
5,083
1,810
441
3,214
311
-1,386
-1,152
3,258
7,744
31,889
38,754
30,879
33,033
26,344
11,112
4,972
-2,719
-2,289
-2,289-2,7194,97211,11226,34433,03330,87938,75431,8897,7443,258-1,152-1,3863113,2144411,8105,0836,7276,7279,58412,21815,82013,29322,4274,0597,74113,11116,61925,84035,98348,74358,64368,20240,40845,32552,53257,808-97,038-2,788000
   Common Stock
0
0
0
1
0
2
2
2
2
3
3
3
3
3
3
3
3
0
1
1
1
1
1
1
1
2
2
2
2
3
3
4
5
6
8
8
8
8
8
8
9
9
10
10998888886543322221111111033333333222201000
   Retained Earnings Total Equity0-157,879-149,1170-125,131-118,112-118,5260-100,585-87,917-78,754-71,431-62,989-55,400-48,300-44,000-40,157-36,764-32,000-29,000-26,053-23,479-19,897-12,231-3,100-211,154-207,019-200,680-195,735-185,776-174,917-161,375-150,667-140,116-130,209-121,781-114,314-108,756-101,3530000
   Accumulated Other Comprehensive Income -419-404-373-351-531-300-164-155-170-107-98-91-113-113-126-103-112-97-970-78-59-32-18-10-83-1,392-1,39200-1,146-1,14600-1,490-1,490000-1,532000
   Capital Surplus 
0
0
0
0
4,315
166,562
166,844
167,104
170,615
208,315
209,307
210,115
210,897
211,613
212,351
213,788
214,757
215,213
25,536
25,541
35,748
35,755
35,714
35,792
35,890
41,942
42,077
44,565
51,613
55,822
61,713
70,366
82,106
95,763
132,636
0
149,560
151,437
151,997
0
154,453
155,556
0
0155,556154,4530151,997151,437149,5600132,63695,76382,10670,36661,71355,82251,61344,56542,07741,94235,89035,79235,71435,75535,74825,54125,536215,213214,757213,788212,351211,613210,897210,115209,307208,315170,615167,104166,844166,5624,3150000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
97,182
-419,685
166,562
166,844
168,594
170,615
208,315
209,307
211,261
210,897
211,613
212,351
215,180
214,757
215,296
25,536
25,541
35,748
35,755
35,714
-97
35,792
41,942
42,077
44,565
51,613
55,822
61,713
70,366
82,106
95,763
132,636
149,028
149,560
151,437
151,997
152,530
154,453
155,556
164,299
164,299155,556154,453152,530151,997151,437149,560149,028132,63695,76382,10670,36661,71355,82251,61344,56542,07741,94235,792-9735,71435,75535,74825,54125,536215,296214,757215,180212,351211,613210,897211,261209,307208,315170,615168,594166,844166,562-419,68597,182000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,000
Cost of Revenue--
Gross Profit-1,000
 
Operating Income (+$)
Gross Profit-
Operating Expense-42,999
Operating Income-41,999-42,999
 
Operating Expense (+$)
Research Development30,715
Selling General Administrative12,284
Selling And Marketing Expenses-
Operating Expense42,99942,999
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-41,999
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-41,047-42,951
EBIT - interestExpense = 0
-41,047
-41,047
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--41,047
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-41,047
Tax Provision--
Net Income From Continuing Ops-41,047-41,047
Net Income-41,047
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net9520
 

Technical Analysis of Dare Bioscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dare Bioscience Inc. The general trend of Dare Bioscience Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dare Bioscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dare Bioscience Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.5899 < 0.6 < 0.66.

The bearish price targets are: 0.53 > 0.53 > 0.45.

Tweet this
Dare Bioscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dare Bioscience Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dare Bioscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dare Bioscience Inc. The current macd is 0.01958.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dare Bioscience Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dare Bioscience Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dare Bioscience Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dare Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartDare Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dare Bioscience Inc. The current adx is 15.13.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Dare Bioscience Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dare Bioscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dare Bioscience Inc. The current sar is 0.43672.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Dare Bioscience Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dare Bioscience Inc. The current rsi is 52.08. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Dare Bioscience Inc Daily Relative Strength Index (RSI) ChartDare Bioscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dare Bioscience Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dare Bioscience Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Dare Bioscience Inc Daily Stochastic Oscillator ChartDare Bioscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dare Bioscience Inc. The current cci is 31.46.

Dare Bioscience Inc Daily Commodity Channel Index (CCI) ChartDare Bioscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dare Bioscience Inc. The current cmo is -0.34924818.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dare Bioscience Inc Daily Chande Momentum Oscillator (CMO) ChartDare Bioscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dare Bioscience Inc. The current willr is -53.65665897.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dare Bioscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dare Bioscience Inc Daily Williams %R ChartDare Bioscience Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dare Bioscience Inc.

Dare Bioscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dare Bioscience Inc. The current atr is 0.04979428.

Dare Bioscience Inc Daily Average True Range (ATR) ChartDare Bioscience Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dare Bioscience Inc. The current obv is -20,337,213.

Dare Bioscience Inc Daily On-Balance Volume (OBV) ChartDare Bioscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dare Bioscience Inc. The current mfi is 42.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Dare Bioscience Inc Daily Money Flow Index (MFI) ChartDare Bioscience Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dare Bioscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Dare Bioscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dare Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.084
Ma 20Greater thanMa 500.500
Ma 50Greater thanMa 1000.422
Ma 100Greater thanMa 2000.381
OpenGreater thanClose0.550
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dare Bioscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Dare Bioscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dare Bioscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dare Bioscience Inc

I send you an email if I find something interesting about Dare Bioscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Dare Bioscience Inc.

Receive notifications about Dare Bioscience Inc in your mailbox!